Search Within

Parastoo Bahrami Dahi

  1. "Executive Committee, Center for Hematologic Malignancies"
Formats
  1. Meeting Abstract (21)
  2. Journal Article (9)
Groups
  1. Bone Marrow Transplant (30)
  2. CTCR Scholars (30)
  3. Center for Hematologic Malignancies (30)
  4. Department of Medicine (30)
  5. Executive Committee, Center for Hematologic Malignancies (30)
  6. Hematologic Malignancies, Division of (30)

More Groups

People
  1. Miguel-Angel Perales (28)
  2. Marcel Van Den Brink (27)
  3. Sergio Giralt (27)
  4. Craig Sauter (26)
  5. Doris Ponce (22)
  6. Sean Devlin (22)

More People

Years
  1. 2023 (1)
  2. 2022 (3)
  3. 2021 (2)
  4. 2020 (4)
  5. 2019 (4)
  6. 2018 (6)

More Years

Publications
  1. Biology of Blood and Marrow Transplantation (11)
  2. Blood (11)
  3. Blood Advances (2)
  4. Bone Marrow Transplantation (2)
  5. Journal of Clinical Investigation (1)
  6. Journal of Clinical Oncology (1)

More Publications

Publishers
  1. American Society of Hematology (13)
  2. Elsevier Inc. (12)
  3. Nature Publishing Group (2)
  4. American Association for the Advancement of Science (1)
  5. American Society for Clinical Investigation (1)
  6. American Society of Clinical Oncology (1)

Results (30)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A reproducible inflammatory biomarker signature identifies non-Hodgkin lymphoma patients at high risk of CAR-T treatment failure across different cohorts
    Meeting Abstract

    Raj, S.; Perales, M. A.; Fei, T.; Fein, J.; Tomas, A. A.; De LaPuerta, M. C.; Dahi, P.; Danylesko, I.; Epstein-Peterson, Z.; Fried, S.; more...
    Bone Marrow Transplantation (2023)

    Fulltext@MSK | Save
  • Inflammatory biomarker clusters are predictive of response and toxicity in large B-cell lymphoma treated with CD19 CAR-T cell therapy
    Meeting Abstract

    Raj, S.; Perales, M. A.; Fein, J. A.; Tomas, A. A.; Batlevi, C. L.; De Lapuerta, M. C.; Dahi, P. B.; Danylesko, I.; Fried, S.; Funnell, T.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • The Simplified Comorbidity Index: A new tool for prediction of nonrelapse mortality in allo-HCT
    Journal Article

    Shouval, R.; Fein, J. A.; Cho, C.; Avecilla, S. T.; Ruiz, J.; Alarcon Tomas, A.; Sanchez-Escamilla, M.; Castillo Flores, N.; Yáñez, L.; Barker, J. N.; more...
    Blood Advances (2022)

    Fulltext@MSK | Save
  • Impact of TP53 genomic alterations in large B-cell lymphoma treated with CD19-chimeric antigen receptor T-cell therapy
    Journal Article

    Shouval, R.; Alarcon Tomas, A.; Fein, J. A.; Flynn, J. R.; Markovits, E.; Mayer, S.; Afuye, A. O.; Alperovich, A.; Anagnostou, T.; Besser, M. J.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Cellular therapy during COVID-19: Lessons learned and preparing for subsequent waves
    Journal Article

    Nawas, M. T.; Shah, G. L.; Feldman, D. R.; Ruiz, J. D.; Robilotti, E. V.; Aslam, A. A.; Dundas, M.; Kamboj, M.; Barker, J. N.; Cho, C.; more...
    Transplantation and Cellular Therapy (2021)

    Fulltext@MSK | Save
  • Fecal microbiota diversity disruption and clinical outcomes after auto-HCT: A multicenter observational study
    Journal Article

    Khan, N.; Lindner, S.; Gomes, A. L. C.; Devlin, S. M.; Shah, G. L.; Sung, A. D.; Sauter, C. S.; Landau, H. J.; Dahi, P. B.; Perales, M. A.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Implications of novel risks scores (AML-DRG and AML-HCT-CR) in allogeneic CD34+ selected graft transplant outcomes
    Meeting Abstract

    Trillo, R. A.; Recio, M. G.; Pennisi, M.; Cho, C.; Devlin, S. M.; Ruiz, J. D.; Maloy, M. A.; Tomas, A. A.; Castillo, N.; Lin, R. J.; more...
    Bone Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Favorable outcomes of COVID-19 in recipients of hematopoietic cell transplantation
    Journal Article

    Shah, G. L.; DeWolf, S.; Lee, Y. J.; Tamari, R.; Dahi, P. B.; Lavery, J. A.; Ruiz, J.; Devlin, S. M.; Cho, C.; Peled, J. U.; more...
    Journal of Clinical Investigation (2020)

    Fulltext@MSK | Save
  • Outcomes in patients with DLBCL treated with commercial CAR T cells compared with alternate therapies
    Journal Article

    Sermer, D.; Batlevi, C.; Lia Palomba, M.; Shah, G.; Lin, R. J.; Perales, M. A.; Scordo, M.; Dahi, P.; Pennisi, M.; Afuye, A.; more...
    Blood Advances (2020)

    Fulltext@MSK | Save
  • Don't let the HCT-CI fool you: Similar outcomes with myeloablative CD34+ selected allo-HCT compared to unmodified RIC allo-HCT in patients with AML or MDS and high comorbidity scores
    Meeting Abstract

    Pennisi, M.; Cho, C.; Devlin, S. M.; Ruiz, J. D.; Maloy, M. A.; Tomas, A. A.; Castillo, N.; Lin, R. J.; Politikos, I.; Sanchez-Escamilla, M.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save